Rani Therapeutics to Participate in Upcoming Investor Conferences
Rani Therapeutics Holdings (Nasdaq: RANI), a clinical-stage biotherapeutics company, will participate in three upcoming investor conferences.
The company's management team will attend the UBS Global Healthcare Conference at Terranea Resort, Rancho Palos Verdes, CA on November 14, 2024, at 10:15am PT, the Stifel Healthcare Conference at Lotte New York Palace Hotel, New York, NY on November 18, 2024, at 4:10pm ET, and the 7th Annual Evercore ISI HealthCONx Conference at The Loews Coral Gables Hotel, Coral Gables, FL on December 4, 2024, at 12:55pm ET.
Each event will feature a fireside chat and 1x1 meetings. Interested parties can register and access live webcasts via the “Events” section of the Rani Therapeutics website. Webcast replays will be available post-event.
Rani Therapeutics Holdings (Nasdaq: RANI), azienda di bioterapeutici in fase clinica, parteciperà a tre prossimi conferenze per investitori.
Il team di gestione dell'azienda sarà presente alla UBS Global Healthcare Conference presso il Terranea Resort, Rancho Palos Verdes, CA, il 14 novembre 2024, alle 10:15 PT, alla Stifel Healthcare Conference presso il Lotte New York Palace Hotel, New York, NY, il 18 novembre 2024, alle 16:10 ET, e alla 7th Annual Evercore ISI HealthCONx Conference presso il The Loews Coral Gables Hotel, Coral Gables, FL, il 4 dicembre 2024, alle 12:55 ET.
Ogni evento includerà una discussione conviviale e incontri individuali. Le parti interessate possono registrarsi e accedere ai webcast dal vivo tramite la sezione “Eventi” del sito web di Rani Therapeutics. Le repliche dei webcast saranno disponibili dopo l'evento.
Rani Therapeutics Holdings (Nasdaq: RANI), una empresa de bioterapéuticos en fase clínica, participará en tres conferencias para inversores próximas.
El equipo de gestión de la empresa asistirá a la UBS Global Healthcare Conference en el Terranea Resort, Rancho Palos Verdes, CA, el 14 de noviembre de 2024, a las 10:15 PT, a la Stifel Healthcare Conference en el Lotte New York Palace Hotel, Nueva York, NY, el 18 de noviembre de 2024, a las 16:10 ET, y a la 7th Annual Evercore ISI HealthCONx Conference en el The Loews Coral Gables Hotel, Coral Gables, FL, el 4 de diciembre de 2024, a las 12:55 ET.
Cada evento contará con una charla informal y reuniones individuales. Las partes interesadas pueden registrarse y acceder a las transmisiones web en vivo a través de la sección “Eventos” del sitio web de Rani Therapeutics. Las repeticiones de las transmisiones estarán disponibles después del evento.
라니 생명과학 홀딩스 (Nasdaq: RANI), 임상 단계의 바이오 의약품 회사가 다가오는 세 가지 투자자 회의에 참가할 예정입니다.
회사의 경영팀은 2024년 11월 14일 오전 10시 15분 PT에 Terranea Resort, Rancho Palos Verdes, CA에서 열리는 UBS 글로벌 헬스케어 컨퍼런스, 2024년 11월 18일 오후 4시 10분 ET에 Lotte New York Palace Hotel, New York, NY에서 열리는 Stifel 헬스케어 컨퍼런스, 그리고 2024년 12월 4일 오후 12시 55분 ET에 The Loews Coral Gables Hotel, Coral Gables, FL에서 열리는 제7회 Evercore ISI HealthCONx 컨퍼런스에 참석할 예정입니다.
각 이벤트는 담소 및 1:1 미팅이 포함될 예정입니다. 관심 있는 분들은 Rani Therapeutics 웹사이트의 '이벤트' 섹션을 통해 등록하고 실시간 웨비나에 접근할 수 있습니다. 이벤트 후 웨비나 재방송이 제공됩니다.
Rani Therapeutics Holdings (Nasdaq: RANI), une entreprise de biothérapeutiques en phase clinique, participera à trois prochaines conférences pour investisseurs.
L'équipe de direction de l'entreprise sera présente à la UBS Global Healthcare Conference au Terranea Resort, Rancho Palos Verdes, CA, le 14 novembre 2024 à 10h15 PT, à la Stifel Healthcare Conference au Lotte New York Palace Hotel, New York, NY, le 18 novembre 2024 à 16h10 ET, et à la 7th Annual Evercore ISI HealthCONx Conference à The Loews Coral Gables Hotel, Coral Gables, FL, le 4 décembre 2024 à 12h55 ET.
Chaque événement comportera un entretien informel et des réunions individuelles. Les parties intéressées peuvent s'inscrire et accéder aux webcasts en direct dans la section « Événements » du site Web de Rani Therapeutics. Les rediffusions des webcasts seront disponibles après l'événement.
Rani Therapeutics Holdings (Nasdaq: RANI), ein Unternehmen für biotherapeutische Arzneimittel in klinischer Phase, wird an drei bevorstehenden Investorenkonferenzen teilnehmen.
Das Management-Team des Unternehmens wird am 14. November 2024 um 10:15 PT an der UBS Global Healthcare Conference im Terranea Resort, Rancho Palos Verdes, CA, am 18. November 2024 um 16:10 ET an der Stifel Healthcare Conference im Lotte New York Palace Hotel, New York, NY, und am 4. Dezember 2024 um 12:55 ET an der 7th Annual Evercore ISI HealthCONx Conference im The Loews Coral Gables Hotel, Coral Gables, FL teilnehmen.
Jede Veranstaltung wird ein Gespräch am Kamin und Einzelgespräche umfassen. Interessierte Parteien können sich registrieren und über den Abschnitt „Veranstaltungen“ auf der Website von Rani Therapeutics auf Live-Webcasts zugreifen. Die Wiederholungen der Webcasts werden nach der Veranstaltung verfügbar sein.
- None.
- None.
SAN JOSE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the company’s management team will participate in three upcoming conferences. These conferences include:
UBS Global Healthcare Conference
Location: Terranea Resort, Rancho Palos Verdes, CA
Date: Thursday, November 14, 2024 at 10:15am PT
Format: Fireside Chat and 1x1 Meetings
Stifel Healthcare Conference
Location: Lotte New York Palace Hotel, New York, NY
Date: Monday, November 18, 2024 at 4:10pm ET
Format: Fireside Chat and 1x1 Meetings
7th Annual Evercore ISI HealthCONx Conference
Location: The Loews Coral Gables Hotel, Coral Gables, FL
Date: Wednesday, December 4, 2024 at 12:55pm ET
Format: Fireside Chat and 1x1 Meetings
Interested parties can register for and access the live webcasts for these conferences by visiting the “Events” section of the Rani Therapeutics website. The webcast replays will be available after the conclusion of the respective presentations.
About Rani Therapeutics
Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill® capsule, which is a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill® capsule technology. For more information, visit ranitherapeutics.com.
Investor Contact:
investors@ranitherapeutics.com
Media Contact:
media@ranitherapeutics.com
FAQ
When is Rani Therapeutics participating in the UBS Global Healthcare Conference?
Where will the Stifel Healthcare Conference take place?
What is the format of Rani Therapeutics' presentations at the upcoming conferences?
How can I access the live webcasts of Rani Therapeutics' conference presentations?
When is the 7th Annual Evercore ISI HealthCONx Conference scheduled?
What is the stock symbol for Rani Therapeutics?
